Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion ...

Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of its latest peer-reviewed paper in Scientific Reports: "A brief visual ...

Kyocera Corporation (President: Hideo Tanimoto; “Kyocera”)(TOKYO: 6971) announced that it has developed a new meta-lens that ...

Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

A device smaller than a grain of dust is emerging as a surprisingly powerful candidate to reshape how quantum computers are ...

Impressively, the unit registered the lowest frequency loss of any chip to date. Specifically, the engineers noted that the new chip was 15x more stable and 100x more efficient in terms of microwave ...

Modulation advances have fueled more efficient use of bandwidth, although conventional modulation formats still require allowance for upper and lower sidebands around the carrier frequency. Ultra ...

A new microchip-sized device could dramatically accelerate the future of quantum computing. It controls laser frequencies ...

BHVN’s investment case definitely weakened after Opakalim’s Phase 2 MDD miss. This also means they’ll discontinue their ...

Atomic-scale imperfections in graphene transistors generate unique wireless fingerprints that cannot be copied or predicted, ...

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopeniaNovel treatment targets BTK through multi-immune ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...